Several studies have shown that the gene expression of NLRP3 inflammasome components, pro-IL-18, and pro-IL-1β was markedly increased in the liver of NASH patients [11, 13]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatohepatitis.